Abstract

The importance of transglutaminase 2 (TG2) in angiogenesis has been highlighted in recent studies, but other roles of this multi-functional enzyme in endothelial cell (EC) function still remains to be fully elucidated. We previously showed that the extracellular TG2 is involved in maintaining tubule formation in ECs by a mechanism involving matrix-bound vascular endothelial growth factor (VEGF) signalling. Here, by using the ECs and fibroblast co-culture and ECs 3D culture models, we demonstrate a further role for TG2 in both endothelial tubule formation and in tubule loss, which involves its role in the regulation of transforming growth factor β1 (TGFβ1) and Smad signalling. We demonstrate that inhibition of tubule formation by TG2 inhibitors can be restored by add-back of exogenous TGFβ1 at pg/ml levels and show that TG2 −/− mouse ECs are unable to form tubules in 3D culture and display negligible Smad signalling compared to wild-type cells. Loss of tubule formation in the TG2 −/− ECs can be reconstituted by transduction with TG2. We demonstrate that extracellular TG2 also has an important role in TGFβ1-induced transition of ECs into myofibroblast-like cells (endothelial–mesenchymal transition), resulting in loss of EC tubules and tubule formation. Our data also indicate that TG2 may have a role in regulating TGFβ signalling through entrapment of active TGFβ1 into the extracellular matrix. In conclusion, our work demonstrates that TG2 has multi-functional roles in ECs where its ability to fine-tune of TGFβ1 signalling means it can be involved in both endothelial tubule formation and tubule rarefaction.

Highlights

  • The process of blood vessel growth, known as angiogenesis, is essential during organ development and tissue repair for the supply of nutrients and oxygen to organs and tissues

  • We sought to establish the relationship between transglutaminase 2 (TG2) and transforming growth factor β1 (TGFβ1) and the importance of this relationship in endothelial tubule formation and in endothelial–mesenchymal transition (EndMT)

  • This observation was confirmed using a human umbilical vein ECs (HUVECs)-fibroblast co-culture angiogenesis model where we demonstrate that a further role for TG2 in angiogenesis is in the deposition of a fibronectin matrix during tubule formation

Read more

Summary

Introduction

The process of blood vessel growth, known as angiogenesis, is essential during organ development and tissue repair for the supply of nutrients and oxygen to organs and tissues. TGFβ1 signalling is thought to be vital in blood vessel morphogenesis and stability.[1] A number of cardiovascular disorders in humans are associated with mutations affecting TGFβ1 signalling, while in mouse knockout models involving components of TGFβ1 signalling lead to severe impairment of angiogenesis.[2] the effects of TGFβ1 on angiogenesis are often contradictory since TGFβ1 has been observed to act as both a stimulator and an inhibitor of angiogenesis in vivo and in vitro.[3] For example, during fibrosis where TGFβ levels are high, the accumulation of fibrotic tissue (e.g., collagens) in the organ is generally accompanied by the loss and dysfunction of blood vessels, referred to as capillary rarefaction.[4] The actual mechanisms of capillary rarefaction remains unclear and contradictory It has been well-established that TGFβ is one of the driving forces in the loss of endothelial characteristics and the gain of mesenchymal phenotype termed endothelial–mesenchymal transition (EndMT) leading to the disruption and loss of blood vessel structures. Inhibition of TG2 by its specific small-molecule inhibitors, shRNA silencing or by inhibitory antibodies of TG2 leads to delayed tubule formation

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.